Joan D. Beckman (@jd_beckman) 's Twitter Profile
Joan D. Beckman

@jd_beckman

Heme physician-scientist. Grew up in ND. Lois & Richard King Assistant Professor at University of Minnesota. #bison #gophers #cats. All opinions are my own.

ID: 2906541911

calendar_today05-12-2014 16:41:01

4,4K Tweet

2,2K Followers

4,4K Following

Lachelle Dawn (@lachelle_dawn) 's Twitter Profile Photo

We must press forward at all times... Now online for @BloodJournal "Sickle Cell Trait Does Not Cause "Sickle Cell Crisis" Leading to Exertion-Related Death: A Systematic Review" Roger Mitchell Jr MD Shematologist, MD Pat McGann, MD Rakhi Naik, MD MHS ashpublications.org/blood/article/…

UMN Medical School (@umnmedschool) 's Twitter Profile Photo

Winter = lower blood supply! ❄️🩸 With the holidays, travel, and cold weather, donations dip. Help save lives by donating. Learn more about donation ➡️ bit.ly/3CtRt1c. #DonateBlood | #Blood

Winter = lower blood supply! ❄️🩸 

With the holidays, travel, and cold weather, donations dip. 

Help save lives by donating. Learn more about donation ➡️ bit.ly/3CtRt1c.

#DonateBlood | #Blood
Senator Patty Murray (@pattymurray) 's Twitter Profile Photo

Trump's proposal is ILLEGAL & amounts to an indiscriminate funding cut for research centers of all sizes, NOT just Ivies. It will mean shuttering labs across the country, layoffs in red & blue states, & derailing lifesaving research on everything from cancer to opioid addiction.

Tony Zador (@tonyzador) 's Twitter Profile Photo

NIH funding supported : *** 412,041 jobs *** *** $92.89 billion in new economic activity*** *** $2.46 for every NIH $1 spent.*** We are a $100B industry. Let's act like it ! How about, at a bare minimum, we all just call our congressional reps??

Amy Klobuchar (@amyklobuchar) 's Twitter Profile Photo

Cuts to NIH funding by the Trump Administration will delay life-saving treatments and undermine our ability to combat diseases like cancer and heart disease. This short-sighted decision will impact lives and life-saving research across the country, including in Minnesota.

GI & Hepatology Division - University of Minnesota (@umn_gihep) 's Twitter Profile Photo

🚨Faculty Highlight🚨 Dr. Alexa Weingarden (Alexa Weingarden MD PhD) joined GI & Hepatology Division - University of Minnesota this summer! She studies how the immune system interacts with gut microbes to drive celiac disease. She will present findings from her work on food allergy in a plenary session at #DDW2025! 👏

🚨Faculty Highlight🚨
Dr. Alexa Weingarden (<a href="/AlexaWeingarden/">Alexa Weingarden MD PhD</a>) joined <a href="/UMN_GIHep/">GI & Hepatology Division - University of Minnesota</a> this summer!

She studies how the immune system interacts with gut microbes to drive celiac disease.

She will present findings from her work on food allergy in a plenary session at #DDW2025! 👏
Marc Carrier (@marccarrier1) 's Twitter Profile Photo

The RENOVE trial found that while low-dose DOACs did not meet non-inferiority for preventing recurrent VTE, it showed a better risk-benefit ratio, with less clinically relevant bleeding. Dose reduction may be a good option for many patients! thelancet.com/journals/lance… Francis Couturaud

UMN Medical School (@umnmedschool) 's Twitter Profile Photo

Don't miss the Stem Cell Institute's next seminar! "Targeting inflammatory microglia/macrophages in acute and chronic inflammation" 🎙️ Andrew Crane, PhD 📅 Tuesday, March 18 from 12-1 p.m. 📍 1-110 McGuire Translational Research Facility 🔗 z.umn.edu/SCI_Res_Conf.

Don't miss the Stem Cell Institute's next seminar!

"Targeting inflammatory microglia/macrophages in acute and
chronic inflammation"

🎙️ Andrew Crane, PhD
📅 Tuesday, March 18 from 12-1 p.m.
📍 1-110 McGuire Translational Research Facility
🔗  z.umn.edu/SCI_Res_Conf.
UMN Medical School (@umnmedschool) 's Twitter Profile Photo

Despite their best intentions, cancer doctors don’t always fully appreciate how much time—and life—a person spends being treated for cancer, says Dr. Arjun Gupta from UMN Medicine & M Health Fairview. Read more about “time toxicity” in cancer treatment: bit.ly/3EvcT2q.

FWGBD (@fwgbd) 's Twitter Profile Photo

🩸This #MenstrualHygieneDay let's advocate, educate, and empower! Join FWGBD in doing this by reading our #MHDay2025 newsletter here: conta.cc/3FuzNr6

🩸This #MenstrualHygieneDay let's advocate, educate, and empower! Join FWGBD in doing this by reading our #MHDay2025 newsletter here: conta.cc/3FuzNr6
Ruben A. Mesa, MD (@mpdrc) 's Twitter Profile Photo

Ropeginterferon Alfa-2b Demonstrates Superior Efficacy & Safety to Anagrelide as 2L for ET - honored to have shared this yesterday during #ASCO25 ⁦Atrium Health Wake Forest Baptist⁩ Comprehensive Cancer Center ⁦⁦Levine Cancer⁩ ⁦PharmaEssentia⁩ dailynews.ascopubs.org/do/ropeginterf…

Tzu-Fei Wang (@tzufeiwang) 's Twitter Profile Photo

Hot off the press! COBBRA trial showed that apixaban is associated with >50% reduced risk of clinically-relevant bleeding symptoms for acute VTE treatment. This can be practice changing! Lana Castellucci Marc Rodger CanVECTOR Network

Hot off the press! COBBRA trial showed that apixaban is associated with &gt;50% reduced risk of clinically-relevant bleeding symptoms for acute VTE treatment. This can be practice changing!
<a href="/LanaCastellucci/">Lana Castellucci</a> <a href="/RodgerMarc/">Marc Rodger</a> <a href="/canvector/">CanVECTOR Network</a>
Mary Cushman 🫀🧠🩸 (@marycushmanmd) 's Twitter Profile Photo

How often do your MPN patients get joint arthroplasty? In this analysis of claims data: ♥️ MPN patients had ⬆️ rates of VTE, bleeding, readmission 💙 higher healthcare utilization More info needed but beware the risks as you plan thrombosis prevention in these patients #ISTH2025

How often do your MPN patients get joint arthroplasty? In this analysis of claims data:
♥️ MPN patients had ⬆️ rates of VTE, bleeding, readmission
💙 higher healthcare utilization
More info needed but beware the risks as you plan thrombosis prevention in these patients
#ISTH2025